YOLFTbeta
Euroespes S.A.

Euroespes S.A.

EEP · MC · Healthcare / Diagnostics & Research

0.34EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.34
Open0.34
Day Range0.34 – 0.34
52-Week Range0.34 – 0.54
Volume0
Market Cap3.95M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.07
50-Day Avg0.54
200-Day Avg0.54

About

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory, nursing, and cardiology. In addition, it researches and develops in the fields of biochemistry, health biotechnology, epigenetics, pharmacogenomics, and nutraceuticals. The company was founded in 1991 and is based in Corunna, Spain.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Ramon Cacabelos Garcia
  • Employees39
  • HeadquartersSanta Marta de BabIo s/n, Corunna, Spain, 15165, Spain
  • Websitehttps://www.euroespes.com

Leadership

  • Mr. Ramon Cacabelos GarciaPresident of the Board & CEO
  • Mr. Francisco Javier Casal LlorenteSecretary of the Board

Financials

Income Statement

Currency: EUR2010-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.33M2.50M2.86M2.53M2.60M2.55M2.37M2.52M3.29M3.30M2.95M2.91M2.88M
Growth (%)--24.90%+14.29%-11.39%+2.47%-1.81%-6.82%+6.27%+30.43%+0.21%-10.45%-1.52%-0.92%
Cost of Revenue774.15K1.40M1.56M-403.73K-180.14K383.43K267.02K141.01K101.77K1.59M242.82K340.15K287.98K
Gross Profit2.56M1.10M1.30M2.94M2.78M2.17M2.11M2.38M3.19M1.70M2.71M2.57M2.59M
Gross Margin76.76%43.99%45.39%115.94%106.94%84.96%88.76%94.41%96.91%51.67%91.78%88.31%90.01%
Operating Expense2.45M921.35K985.70K2.55M2.37M2.41M2.93M2.72M3.44M3.09M4.12M2.83M2.55M
Operating Income109.84K179.05K311.78K390.36K406.77K-249.00K-826.71K-335.24K-247.41K-1.39M-1.41M-256.55K41.64K
Operating Margin3.30%7.16%10.91%15.41%15.67%-9.77%-34.81%-13.28%-7.52%-42.00%-47.60%-8.82%1.44%
EBITDA----670.63K110.54K-242.39K229.70K665.25K-192.71K---
EBITDA Margin----25.84%4.34%-10.21%9.10%20.21%-5.84%---
Net Income87.39K178.96K207.23K343.34K105.42K-254.25K-1.26M-411.34K-183.44K-1.14M-2.13M-323.18K923.08
Net Income Margin2.62%7.15%7.25%13.55%4.06%-9.98%-52.98%-16.30%-5.57%-34.47%-72.25%-11.11%0.03%
Interest Expense00000152.03K96.83K82.95K94.82K103.77K220.91K42.30K47.38K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%5.97%4.08%3.29%2.88%3.15%7.48%1.45%1.64%

Balance Sheet

Currency: EUR2010-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.11M6.33M6.73M8.90M9.35M12.76M11.37M11.70M12.25M11.42M7.93M6.94M6.42M
Total Liabilities1.13M3.59M3.65M4.63M4.78M3.96M3.92M4.26M4.82M5.22M5.04M4.37M3.77M
Total Equity3.98M2.75M3.08M3.81M4.10M8.41M7.14M7.44M7.43M6.20M2.89M2.57M2.65M
Cash451.63K186.34K99.34K71.13K17.11K3.43M2.34M2.22M1.97M971.10K422.90K217.37K443.17K
Net Debt----3.32M-415.58K939.74K1.70M3.19M3.42M3.24M2.55M

Cash Flow

Currency: EUR2010-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow91.88K91.88K414.91K451.25K911.75K45.47K-510.28K-287.52K16.60K-647.82K556.08K70.53K622.18K
Investing Cash Flow-331.70K-331.70K-607.20K-1.08M-1.05M-365.27K-294.30K-142.39K-759.81K-717.03K---
Financing Cash Flow163.94K163.94K105.29K584.06K81.97K3.73M-285.82K312.79K491.01K364.74K---
Capital Expenditure40.81K40.81K230.01K7.07K231.60K109.05K230.58K60.27K95.01K717.03K523.29K200.51K245.60K
Free Cash Flow-----140.66K-461.21K-804.58K-429.92K-184.12K-1.36M32.79K-129.99K376.58K
FCF to OCF-----15.43%-1014.35%157.67%149.52%-1109.07%210.68%5.90%-184.31%60.53%

Key Statistics & Ratios

Market Cap3.95M
Enterprise Value7.13M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.02
Price / Book0.88
EPS-0.01
Book Value0.574
Revenue (TTM)3.86M
Gross Profit (TTM)1.68M
EBITDA-824.34K
Profit Margin-29.49%
Operating Margin-44.70%
Return on Equity-16.69%
Return on Assets-5.90%
Shares Outstanding11.61M
Shares Float8.65M
Beta0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%